Literature DB >> 28779283

Clofibrate in Neonatal Hyperbilirubinemia.

Deepak Chawla1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28779283     DOI： 10.1007/s12098-017-2438-6

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  7 in total

1.  Neonatal jaundice: summary of NICE guidance.

Authors:  Janet Rennie; Shona Burman-Roy; M Stephen Murphy
Journal:  BMJ       Date:  2010-05-19

Review 2.  Hyperbilirubinemia in the newborn infant > or =35 weeks' gestation: an update with clarifications.

Authors:  M Jeffrey Maisels; Vinod K Bhutani; Debra Bogen; Thomas B Newman; Ann R Stark; Jon F Watchko
Journal:  Pediatrics       Date:  2009-09-28       Impact factor: 7.124

3.  Evaluation of the carcinogenic potential of clofibrate in the rasH2 mouse.

Authors:  Sarah R Nesfield; Christopher J Clarke; Debie J Hoivik; Richard T Miller; Jane S Allen; Krzysztof Selinger; Michael J Santostefano
Journal:  Int J Toxicol       Date:  2005 Sep-Oct       Impact factor: 2.032

4.  Evaluation of the carcinogenic potential of clofibrate in the FVB/Tg.AC mouse after dermal application--part II.

Authors:  Carla E Torrey; Henry G Wall; James A Campbell; Puntipa Kwanyuen; Debie J Hoivik; Richard T Miller; Jane S Allen; Manuel J Jayo; Krzysztof Selinger; Michael J Santostefano
Journal:  Int J Toxicol       Date:  2005 Sep-Oct       Impact factor: 2.032

Review 5.  Clofibrate in combination with phototherapy for unconjugated neonatal hyperbilirubinaemia.

Authors:  Maryam Gholitabar; Hugh McGuire; Janet Rennie; Donal Manning; Rosalind Lai
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

6.  Clofibrate as an Adjunct to Phototherapy for Unconjugated Hyperbilirubinemia in Term Neonates.

Authors:  Prasad Kumar; B Adhisivam; B Vishnu Bhat
Journal:  Indian J Pediatr       Date:  2017-05-17       Impact factor: 1.967

7.  WHO cooperative trial on primary prevention of ischaemic heart disease with clofibrate to lower serum cholesterol: final mortality follow-up. Report of the Committee of Principal Investigators.

Authors: 
Journal:  Lancet       Date:  1984-09-15       Impact factor: 79.321
  7 in total
  1 in total

1.  Editor's Highlight: Clofibrate Decreases Bile Acids in Livers of Male Mice by Increasing Biliary Bile Acid Excretion in a PPARα-Dependent Manner.

Authors:  Youcai Zhang; Andrew J Lickteig; Iván L Csanaky; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2017-12-01       Impact factor: 4.849
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.